Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Treating Adolescent Obsessive Compulsive Disorder With Transcranial Magnetic Stimulation

NCT: NCT07065669 · RECRUITING

NCT IDNCT07065669
StatusRECRUITING
Start Date2025-06-01
Completion2027-07-01
SponsorUniversity of California, San Francisco (OTHER)
First posted
Last updated

Brief Summary

This is a pilot study to examine the tolerability, safety and early efficacy of two forms of transcranial magnetic stimulation (TMS) for treating adolescents with Obsessive Compulsive Disorder (OCD) who have experienced limited improvements with usual treatments for OCD in adolescents. The project's primary goal is to examine whether adolescents can complete 3 consecutive weeks of TMS administered 5 days per week, and to describe the type of and how common individual side effects with TMS occur in adolescents with OCD. Participants will: * visit the clinic every weekday for 3 weeks (15 days) to receive TMS treatments * have a brain MRI scan before TMS treatments begins and after finishing all TMS * complete questionnaires and report changes in behavior and physical symptoms

Frequently Asked Questions

What is Treating Adolescent Obsessive Compulsive Disorder With Transcranial Magnetic Stimulation?

Treating Adolescent Obsessive Compulsive Disorder With Transcranial Magnetic Stimulation is a clinical trial registered under NCT07065669. Current status: RECRUITING.

What is the status of NCT07065669?

The current status of NCT07065669 (Treating Adolescent Obsessive Compulsive Disorder With Transcranial Magnetic Stimulation) is: RECRUITING.

When did Treating Adolescent Obsessive Compulsive Disorder With Transcranial Magnetic Stimulation start?

Treating Adolescent Obsessive Compulsive Disorder With Transcranial Magnetic Stimulation started on 2025-06-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.